DOYLESTOWN, Pa., Oct. 15, 2024 /PRNewswire/ — Mid-Atlantic BioTherapeutics, Inc. (the “Company“), a clinical-stage biotechnology company specializing in cutting-edge immunotherapies and central nervous system (“CNS“) disorder treatments, today announced the commencement of a fundraising round …
DOYLESTOWN, Pa., Sept. 4, 2024 /PRNewswire/ — Mid-Atlantic BioTherapeutics (MABT) and Accelero Biostructures (Accelero) are pleased to announce a research collaboration to identify novel USP30 inhibitors targeting neurological disorders and other important …
An adult female fox was confirmed positive for rabies after being captured on the grounds of the U.S. Capitol and being humanely euthanized. The fox bit at least nine people, including one lawmaker and a Politico reporter.
Curative Biotechnology Announces IMT504 License For Development Of Proprietary Next-gen COVID-19 Vaccine License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, October …
Connectyx Technologies Holdings Group, Inc. Announces Strategic Relationship with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies COMPANY TO ACQUIRE WORLDWIDE RIGHTS FOR DEVELOPMENT OF IMT504 Boca Raton, FL, Aug. …